secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcutis Biotherapeutics, Inc. (ARQT)
CIK:        0001787306
Form:       8-K
Filed at:   2021-09-07T23:59:59+00:00
Accession:  0001787306-21-000013
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Arcutis appoints Keith Leonard as Class I director; Ricky Sun resigns without disagreement
--------------------------------------------------------------------------------

- Keith R. Leonard Jr. appointed Class I director, term expiring at 2024 annual meeting, effective Sept 2.
- Ricky Sun resigned from Board effective Sept 2; no disagreement with company operations or policies.
- Leonard joins Compensation Committee; receives 32,907-share stock option (3-year annual vest).
- Annual cash retainer of $40,000 for Board service plus $7,500 for Compensation Committee membership.
- Leonard to enter standard indemnification agreement with Arcutis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787306/000178730621000013/0001787306-21-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787306/000178730621000013/arqt-20210903.htm
  HTML page:      https://secwatch.observer/filing/0001787306-21-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer